Date |
ArticleType |
8/23/2018 |
Insights |
FDA To Issue Pain Management Guidelines |
|
FDA To Issue Pain Management Guidelines by Jennifer Garvin The Food and Drug Administration announced Aug. 22 that it will develop prescribing guidelines in an effort to give health care providers "the most current and comprehensive guidance on the appropriate management of pain." To do this, the FDA said it has awarded a contract to the National Academies of Sciences, Engineering, and Medicine to develop evidence-based guidelines for "appropriate opioid analgesic prescribing for acute pain resulting from specific conditions or procedures." "The primary scope of this work is to understand what evidence is needed to ensure that all current and future clinical practice guidelines for opioid analgesic prescribing are sufficient, and what research is needed to generate that evidence in a practical and feasible manner," said FDA Commissioner Scott Gottlieb, M.D., in prepared remarks. Dr. Gottlieb said the FDA plans to re-examine how opioids are being prescribed since "many common, acute indications" could be treated with "just a day or two of medication rather than a 30-day supply, which is typically prescribed." He also said the FDA is concerned about excess pills being "misused or abused by friends or family members" and the increased risks for misuse, abuse and addiction some patients may face. Strategies for the management of acute pain in medicine and dentistry are the same. Read full article on American Dental Association.
|
|
|